Charcot-Marie-Tooth 1A patients with low level of impairment have a higher energy cost of walking than healthy individuals

Neuromuscular Disorders

Volumn 21, Issue 1, 2011, Pages 52-57

  Menotti, Federica ^a   Felici, Francesco ^a   Damiani, Antonello ^b   Mangiola, Fortunato ^b   Vannicelli, Roberto ^b   Macaluso, Andrea ^a  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

^b Unione Italiana Lotta alla Distrofia Muscolare   (Italy)

Author keywords

Gait; Hereditary neuromuscular disorder; Neuropathies; Oxygen consumption; Walking economy

Indexed keywords

ADULT; ARTICLE; CHARCOT MARIE TOOTH DISEASE TYPE 1A; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENERGY EXPENDITURE; FEMALE; GAIT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; WALKING DIFFICULTY; WALKING SPEED;

EID: 78650306018     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.09.008     Document Type: Article

References (47)

1. Casasnovas C., Cano L.M., Albertí A., Céspedes M., Rigo G. Charcot-Marie-Tooth disease. Foot Ankle Spec 2008, 1:350-354.
2. Banchs I., Casasnovas C., Albertì A., et al. Diagnosis of Charcot-Marie-Tooth disease. J Biomed Biotechnol 2009, 1:1-10.
3. Bamford N.S., White K.K., Robinett S.A., Otto R.K., Gospe S.M. Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A. Dev Med Child Neurol 2008, 51:408-411.
4. Hattori N., Yamamoto M., Yoshihara T., et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelinrelated proteins (pmp22, mpz and cx32): a clinicopathological study of 205 japanese patients. Brain 2003, 126:134-151.
5. Ishpekova B., Christova L.G., Alexandrov A.S., Thomas P.K. The electrophysiological profile of hereditary motor and sensory neuropathy-Lom. J Neurol Neurosurg Psychiatry 2005, 76:875-878.
6. Carter G.T., Abresch R.T., Fowler W.M., Johnson E.R., Kilmer D.D., McDonald C.M. Profiles of neuromuscular diseases. Hereditary motor and sensory neuropathy, types I and II. Am J Phys Med Rehabil 1995, 74:140-149.
7. Lindeman E., Spaans F., Reulen J.P.H., Leffers P., Drukker J. Surface EMG of proximal leg muscles in neuromuscular patients and in healthy controls. Relations to force and fatigue. J Electromyogr Kinesiol 1999, 9:299-307.
8. Kilmer D.D. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 2002, 81:121-126.
9. Padua L., Pareyson D., Aprile I., et al. Natural history of Charcot-Marie-Tooth 2: 2-year follow-up of muscle strength, walking ability and quality of life. Neurol Sci 2009.
10. Kalkman J.S., Schillings M.L., van der Werf S.P., et al. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry 2005, 76:1406-1409.
11. Schillings M.L., Kalkman J.S., Janssen H.M., van Engelen B.G.M., Bleijenberg G., Zwarts M.J. Experienced and physiological fatigue in neuromuscular disorders. Clin Neurophysiol 2007, 118:292-300.
12. Zwarts M.J., Bleijenberg G., van Engelen B.G.M. Clinical neurophysiology of fatigue. Clin Neurophysiol 2008, 119:2-10.
13. Boentert M., Dziewas R., Heidbreder A., et al. Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey. J Neurol 2010, 257:646-652.
14. Geurts A.C., Mulder T.W., Nienhuis B., Mars P., Rijken R.A. Postural organization in patients with hereditary motor and sensory neuropathy. Arch Phys Med Rehabil 1992, 73:569-572.
15. Vinci P., Perelli S.L. Footdrop, foot rotation, and plantarflexor failure in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 2002, 83:513-516.
16. Nardone A., Grasso M., Schieppati M. Balance control in peripheral neuropathy: are patients equally unstable under static and dynamic conditions?. Gait Posture 2006, 23:364-373.
17. Carter G.T., Jensen M.P., Galer B.S., et al. Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 1998, 79:1560-1564.
18. Crosbie J., Burns J., Ouvrier R.A. Pressure characteristics in painful pes cavus feet resulting from Charcot-Marie-Tooth disease. Gait Posture 2008, 28:545-551.
19. El Mhandi L., Millet G.Y., Calmels P., et al. Benefits of interval-training on fatigue and functional capacities in Charcot-Marie-Tooth disease. Muscle Nerve 2008, 37:1-10.
20. Padua L., Shy M.E., Aprile I., et al. Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. J Peripher Nerv Syst 2008, 13:64-70.
21. Wright N.C., Kilmer D.D., McCrory M.A., Aitkens S.G., Holcomb B.J., Bernauer E.M. Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil 1996, 77:64-69.
22. McCrory M., Kim H., Wright N., Lovelady C.A., Aitkens S., Kilmer D.D. Energy expenditure, physical activity, and body composition of ambulatory adults with hereditary neuromuscular disease. Am J Clin Nutr 1998, 67:1162-1169.
23. Aitkens S., Kilmer D.D., Wright N.C., McCrory M.A. Metabolic syndrome in neuromuscular disease. Arch Phys Med Rehabil 2005, 86:1030-1036.
24. Kilmer D.D., Wright N.C., Aitkens S. Impact of a home-based activity and dietary intervention in people with slowly progressive neuromuscular diseases. Archi Phys Med Rehabil 2005, 86:2150-2156.
25. Mazzaro N., Grey M.J., Sinkjær T., Andersen J.B., Pareyson D., Schieppati M. Lack of on-going adaptations in the soleus muscle activity during walking in patients affected by large-fiber neuropathy. J Neurophys 2005, 93:3075-3085.
26. Don R., Serrao M., Vinci P., et al. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Clin Biomech 2007, 22:905-916.
27. Newman C.J., Michael W., O'Sullivan R., et al. The characteristics of gait in Charcot-Marie-Tooth disease types I and II. Gait Posture 2007, 26:120-127.
28. Vinci P. Persistence of range of motion in dorsiflexion when the triceps surae muscle weaken, worsens stance in Charcot-Marie-Tooth disease. Eur Medicophys 2006, 42:219-222.
29. Ramdharry G.M., Day B.L., Reilly M., Marsden J.F. Hip flexors fatigue limits walking in Charcot-Marie-Tooth disease. Muscle Nerve 2009, 40:103-111.
30. Kuruvilla A., Costa J.L., Wright R.B., Yoder D.M., Andriacchi T.P. Characterization of gait parameters in patients with Charcot-Marie-Tooth disease. Neurol India 2000, 48:49-55.
31. Thomas E.E., De Vito G., Macaluso A. Speed training with body weight unloading improves walking energy cost and maximal speed in 75-85year old healthy women. J Appl Physiol 2007, 103:1598-1603.
32. Bernardi M., Macaluso A., Sproviero E., et al. Cost of walking and locomotor impairment. J Electromyogr Kinesiol 1999, 9:149-157.
33. Waters R.L., Mulroy S. The energy expenditure of normal and pathologic gait. Gait Posture 1999, 9:207-231.
34. Fisher S.V., Gullickson G. Energy cost of ambulation in health and disability: a literature review. Arch Phys Med Rehabil 1978, 59:124-133.
35. da Cunha-Filho I.T., Henson H., Wankadia S., Protas E.J. Reliability of measures of gait performance and oxygen consumption with stroke survivors. J Rehabil Res Dev 2003, 40(1):19-25.
36. Brehm M.A., Nollet F., Nollet J. Energy demands of walking in persons with postpoliomyelitis syndrome: relationship with muscle strength and reproducibility. Arch Phys Med Rehabil 2006, 87:136-140.
37. Danielsson A., Willén C., Sunnerhagen K.S. Measurement of energy cost by the physiological cost index in walking after stroke. Arch Phys Med Rehabil 2007, 88:1298-1303.
38. Genin J.J., Bastien G.J., Franck B., Detrembleur C., Willems P.A. Effect of speed on the energy cost of walking in unilateral traumatic lower limb amputees. Eur J Appl Physiol 2008, 103:655-663.
39. Christiansen C.L., Schenkman M.L., McFann K., Wolfe P., Kohry W.M. Walking economy in people with Parkinson's disease. Mov Disord 2009, 24:481-1487.
40. Jacelon C.S. The Barthel index and other indices of functional ability. Rehabil Nurs 1986, 11:9-11.
41. Tinetti M.E. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 1986, 34:119-126.
42. Medical-Research-Council, Aids to the investigation of peripheral nerve injuries. London: Her Majesty's Stationery Office; 1976.
43. Duffield R., Dawson B., Pinnington H.C., Wong P. Accuracy and reliability of a Cosmed K4b2 portable gas analysis system. J Sports Sci Med 2004, 7:11-22.
44. McLaughlin J.E., King G.A., HE T., Bassett D.R.J., BE A. Validation of the Cosmed K4b2 portable metabolic system. Int J Sports Med 2001, 22:280-284.
45. Cunningham C.B., Schilling N., Anders C., Carrier D.R. The influence of foot posture on the cost of transport in humans. J Exp Biol 2010, 213:790-797.
46. Felici F., Bernardi M., Rodio A., Marchettoni P., Castellano V., Macaluso A. Rehabilitation of walking for paraplegic patients by means of a treadmill. Spinal Cord 1997, 35:383-385.
47. Gazzani F., Bernardi M., Macaluso A., et al. Ambulation training of neurological patients on the treadmill with a new Walking Assistance and Rehabilitation Device (WARD). Spinal Cord 1999, 37:336-344.